Table 2 Genotypic and allelic distribution of PRNP codon 129 in AD, FTD patients and controls.
From: Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China
Genotype | Allele | ||||
|---|---|---|---|---|---|
MM | MV | VV | M | V | |
Control | 520 | 14 | 0 | 1054 | 14 |
AD | 585 | 21 | 0 | 1191 | 21 |
FTD | 76 | 1 | 0 | 153 | 1 |
FTD vs Control | |||||
OR | 2.046 | 2.032 | |||
95%CI | 0.265–15.783 | 0.265–15.564 | |||
P value | 0.707 | 0.709 | |||
AD vs Control | |||||
OR | 0.75 | 0.753 | |||
95%CI | 0.378–1.49 | 0.381–1.489 | |||
P value | 0.492 | 0.496 | |||
EOAD vs Control | |||||
OR | 0.888 | 0.789 | |||
95%CI | 0.315–2.504 | 0.318–2.489 | |||
P value | 0.789 | 0.79 | |||
LOAD vs Control | |||||
OR | 0.707 | 0.711 | |||
95%CI | 0.341–1.465 | 0.345–1.464 | |||
P value | 0.358 | 0.362 | |||